BackAlbireo Pharma Overview

Albireo Pharma Total Assets

Track Albireo Pharma's total assets ($320M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$321.22M
8.36% YoYΔ $24.78M vs prior year quarter

Peer trimmed avg / median

Loading

Albireo Pharma Total Assets History

Loading

Albireo Pharma vs. peers: Total Assets Comparison

Loading

Albireo Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Albireo Pharma (ALBO) FAQ

As of the most recent data (September 2022), ALBO shows a total assets of $320M. That compares with $300M in the prior-year period — up 8.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALBO's total assets is now $320M (was $300M) — a 8.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Albireo Pharma is outperforming or lagging.

Tracking ALBO's total assets over time shows whether Albireo Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $320M That compares with $300M in the prior-year period — up 8.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Albireo Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $320M) with ownership activity and broader fundamentals.

Albireo Pharma's total assets is $320M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.